DEVELOPING TARGETED CHEMOTHERAPEUTICS FOR MALIGNANT BRAIN TUMORS USING AN INNOVATIVE BLOOD-BRAIN BARRIER ORGANOID PLATFORM

$574,441FY2019Department of the ArmyDOD

Brigham & Womens Hospital Inc

Investigators